Amit Sachdev
CIK 1406338 · EVP Chief Patient & Ext Af Off · last filed 2026-02-26
Amit Sachdev is an EVP Chief Patient & Ext Af Off who has filed 146 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for VRTX, was dated Feb 26, 2026. Across all open-market trades the lifetime net is −$171.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.86M
2
146
-$171.36M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | EVP Chief Patient & Ext Af Off | 64,871 | $444.93 | $28.86M | -$171.36M | 141 | 2026-02-26 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Director | 16,000 | $1.73 | $27.6K | $0 | 5 | 2023-03-03 |
Recent Filings
146 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-26 | VRTX | Mixed | −3,364 | -$1.63M | EDGAR |
| 2026-02-23 | VRTX | Mixed | −10,108 | -$19.13M | EDGAR |
| 2026-02-19 | VRTX | Mixed | +3,649 | -$1.04M | EDGAR |
| 2026-02-18 | VRTX | Tax (F) | −3,548 | -$1.73M | EDGAR |
| 2026-02-12 | VRTX | Tax (F) | −2,057 | -$963.5K | EDGAR |
| 2026-01-26 | VRTX | Grant (A) | +11,749 | $0 | EDGAR |
| 2025-02-28 | VRTX | Tax (F) | −3,703 | -$1.78M | EDGAR |
| 2025-02-26 | VRTX | Tax (F) | −2,470 | -$1.19M | EDGAR |
| 2025-02-19 | VRTX | Tax (F) | −2,139 | -$991.3K | EDGAR |
| 2025-02-14 | VRTX | Grant (A) | +6,211 | $0 | EDGAR |